RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
-
The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
Authors: Ya-Lin Chiu, Warner C Greene
Annual review of immunology 2008 -
A coming-of-age story: activation-induced cytidine deaminase turns 10.
Authors: Rebecca K Delker, Sebastian D Fugmann, F Nina Papavasiliou
Nature immunology 2009 Nov
Thought leaders and organizations working on research involving arac.
- Robert Schleif
- F Nina Papavasiliou
- Tasuku Honjo
- Jeff M Skredenske
- Jason R Wickstrum
- M.D. Anderson Cancer Center
- Vion Pharmaceuticals
- Johann Wolfgang Goethe University Hospitals
- Weill Medical College of Cornell University
- Children's Oncology Group
- Rockefeller University
- Johns Hopkins University
- University of California
- University of Kansas
- Kyoto University
-
A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)
conditions: Leukemia, Promyelocytic, Acute
interventions: Arac
-
Clofarabine and AraC for the Treatment of AML, MDS
conditions: Acute Myelogenous Leukemia ; Myelodysplastic Syndromes ; Chronic Myelogenous Leukemia
interventions: Clofarabine and AraC Regimen
Community
Oleg Tolmachov
Researcher
CINJ/UMDNJ
-
No NextBio groups were found for “arac”.
Be the first to start a group and share your interests with others within the NextBio community.
